According to the Bangladesh Pharmaceutical Index 2013(1st
Quarter) Total Market size of Bangladesh Pharma Market is Tk 9441 Crore (Local only,
except import and export). As usual Sqaure Pharmaceutical Limited leading in
front with the 18 % of share of total pharma market, though they are slightly
behind from the National Market Growth of 8%. Novo Nordisk has the highest 27%
growth in this market with only 8 Generics (Insulin based), UniMed UniHealth
has the second highest (20%) and Healthcare Pharma (19%) has the third highest
growth in the 1st Quarter’2013.
Pharmaceutical Products of Bangladesh
Description of various medicines, disease profile, drug related study and research.
Monday, August 5, 2013
Wednesday, May 9, 2012
Top 20 Brand of Bangladesh Pharma Market: 2011
SI
|
Brand
|
Company
|
Value
(Cr)
|
GRW
|
Cont% On Total Sale
|
1
|
SECLO
|
Square
|
134
|
37
|
1.67
|
2
|
LOSECTIL
|
SK+F
|
93
|
33
|
1.15
|
3
|
PANTONIX
|
Incepta
|
72
|
37
|
0.90
|
4
|
NAPA
|
Beximco
|
69
|
30
|
0.86
|
5
|
NEOTACK
|
Square
|
68
|
25
|
0.84
|
6
|
CEF-3
|
Square
|
65
|
33
|
0.80
|
7
|
NEOCEPTIN R
|
Beximco
|
64
|
-2.4
|
0.80
|
8
|
MAXPRO
|
Renata
|
56
|
66
|
0.70
|
9
|
ZIMAX
|
Square
|
54
|
23
|
0.67
|
10
|
CIPROCIN
|
Square
|
53
|
13
|
0.66
|
11
|
NAPA EXTRA
|
Beximco
|
44
|
44
|
0.55
|
12
|
XELDRIN
|
ACI
|
43
|
18
|
0.53
|
13
|
VOLTALIN
|
Novartis
|
40
|
46
|
0.50
|
14
|
SERGEL
|
Healtcare
|
40
|
56
|
0.49
|
15
|
FUROCEF
|
Renata
|
34
|
35
|
0.42
|
16
|
LEBAC
|
Square
|
33
|
0.7
|
0.41
|
17
|
CEFTRON
|
Square
|
32
|
-4.1
|
0.40
|
18
|
MIXTARD 30
|
Novo Nor.
|
32
|
36
|
0.39
|
19
|
ROLAC
|
Renata
|
31
|
27
|
0.39
|
20
|
OMEP
|
Aristo
|
31
|
43
|
0.38
|
Subscribe to:
Posts (Atom)